GlaxoSmithKline boosts stake in Saudi Arabia unit
Published Dec 18, 2017 12:43
GlaxoSmithKline boosts stake in Saudi Arabia unit
DUBAI (Reuters) - British drugmaker GlaxoSmithKline (L:GSK) (GSK) said on Monday it has boosted its stake in its Saudi Arabian unit to 75 percent as it seeks to benefit from the kingdom's plan to transform the economy and raise local manufacturing of pharmaceutical products.
Healthcare is one of several sectors the kingdom wants to reform under its 2030 plan to diversify the economy away from a reliance on oil.
Before the acquisition, GSK owned 49 percent of Glaxo Saudi Arabia, a business it formed in 1992 with local partner Banaja KSA Holding Company.
In addition to the acquisition, GSK plans to invest more than 900 million riyals (£180 million) in its Saudi operations over the next three years. It plans to expand production at its Jeddah manufacture site by 30 percent.
"The acquisition represents a step forward towards the strengthening of our operations in the kingdom," said Andrew Miles, vice president and general manager of GSK in the Gulf Cooperation Council states. "Today, 80 percent of our portfolio is locally manufactured in Jeddah."
Get The App
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.